PharmcoRx Pharmacy Launches Mark Cuban Cost Plus Drug Program Expanding Its In-Pharmacy Offerings

December 15, 2023

https://www.prnewswire.com/news-releases/pharmcorx-pharmacy-launches-mark-cuban-cost-plus-drug-program-expanding-its-in-pharmacy-offerings-301997547.html

MIAMI, Nov. 27, 2023 /PRNewswire/ — PharmcoRx Pharmacy, a wholly-owned subsidiary of Progressive Care Inc (OTCQB:RXMD), today announced its expansion of in-pharmacy offerings through an agreement with the Mark Cuban Cost Plus Drug Company (“Cost Plus Drugs”). The Cost Plus Drugs program allows participating patients the ability to purchase generic and branded medicines at their cost plus a low fixed markup.

Read more at prnewswire.com

Related news for (NXPL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.